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Treatment of anorectal Buschke-Löwenstein tumor (BLT) with squamous cell carcinoma (SCC) transformation is not
univocal given the rarity of the disease. BLT is characterized by its large size and tendency to infiltrate into
underlying tissues. Malignant transformation can occur and it is important to identify the presence of neoplastic
foci to decide the proper treatment. Our aim was to assess the effectiveness of neo-adjuvant chemo-radiation
therapy (CRT) and local excision in order to avoid abdomino-perineal resection (APR). Three cases of anorectal BLT
with SCC transformation are presented. All patients were HIV positive and treated with antiretroviral drugs. They
underwent preoperative endoanal ultrasound, biopsies, total body tomography and anal brushing. Treatment
consisted of neo-adjuvant chemo-radiation therapy (45 Gy to the pelvis plus a boost with 14.40 Gy to the primary
tumor for a total of 59.40 Gy, and mitomycin-C in bolus on the first day, plus 5-fluorouracil by continuous infusion
in the first and in the sixth week) and subsequent local surgical excision. During the follow-up, patients were
subjected to the same preoperative diagnostic investigations and high resolution anoscopy. All patients showed a
complete regression of the lesion after CRT and were treated by local surgical excision, thus avoiding permanent
colostomy. In conclusion neo-adjuvant chemo-radiation therapy with local surgical excision could be considered an
effective therapy in the treatment of anorectal BLT with SCC transformation to avoid APR.
Keywords: Buschke-Löwenstein tumor, Human papillomavirus, Giant condyloma acuminatum, Chemo-radiation
therapy, Wide local excisionBackground
The Buschke-Löwenstein tumor (BLT) or giant condyl-
oma acuminatum (GCA) is a large, exophytic, cauliflower
lesion of the anogenital region, correlated to HPV infec-
tion [1]. It is histologically benign and when it is diag-
nosed at an early stage can be treated with wide local
excision [2,3]. Some authors believe that the biological be-
havior of the BLT is an intermediate form between con-
dyloma acuminatum and squamous cell carcinoma [4].
Malignant transformation in squamous cell carcinoma
(SCC) can occur and if not detected early it is no longer
distinguishable from an invasive carcinoma [5]. There are* Correspondence: marileda.indinnimeo@uniroma1.it
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distribution, and reproduction in any mediumdifferent treatments for BLT including local surgical exci-
sion, cryotherapy or topical podophyllin [6]. In the pres-
ence of foci of SCC, therapy is still controversial. We
present three cases of BLT with SCC transformation
treated with chemo-radiation therapy and local surgical
excision.Case presentation
Case one
A 43-year-old homosexual and HIV positive man was ad-
mitted for a large perianal lesion that had given anal dis-
comfort for two months (Figure 1). Endoanal ultrasound
examination (EUS) showed anal canal invasion (uT1N0).
Histological examination on multiple biopsies specimens
showed a characteristic GCA with SCC transformation.
PCR performed on the anal brushing revealed the pres-
ence of HPV-6. The patient submitted to chemo-radiationntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Preoperative appearance of the patient with a
perianal cauliflower-like tumor. The lesion appears exophytic and
infiltrates the perianal tissue.
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fr) to the pelvis plus a boost with 14.40 Gy (1.8 Gy/fr) to
the primary tumor for a total of 59.4 Gy, and mitomycin-C
(10 mg/m2) in a single dose on first day, plus 5-fluorouracil
(750 mg/m2) by continuous infusion in the first and in the
sixth week. He tolerated the treatment well. The tumor
disappeared completely after treatment and perianal and
endoanal local excisions were performed (Figure 2). Histo-
logical examination ruled out the presence of GCA andFigure 2 Perineum after chemo-radiation therapy and local
excision. The lesion has completely disappeared after chemo-
radiation and local excision was subsequently performed.cancer. The patient underwent EUS and high resolution
anoscopy (HRA) twice a year and, after three years, is dis-
ease free.
Case two
A 56-year-old homosexual HIV positive man was admitted
complaining of anal pain and bleeding, mucopurulent peri-
anal discharge and severe incontinence for six months due
to a large perianal ulcerated lesion. EUS showed invasion of
the anal canal by the tumor (uT2) (Figure 3) and histologic
examination on multiple endoanal and perianal biopsies re-
vealed the presence of GCA and foci of SCC. Pathological
inguinal lymph nodes were detected by ultrasound examin-
ation (uN1). PCR performed on the anal brushing revealed
the presence of HPV-6. The patient underwent a temporary
colostomy for severe incontinence and anal fistulas and
submitted to chemo-radiotherapy according to the follow-
ing scheme: 45 Gy (1.8 Gy/fr) to the pelvis plus a boost with
14.40 Gy (1.8 Gy/fr) to the primary tumor for a total of
59.4 Gy, and mitomycin-C (10 mg/m2) in a single dose on
first day plus 5-fluorouracil (750 mg/m2) by continuous in-
fusion in the first and in the sixth week. He tolerated the
treatment well. The perianal GCA did not disappear com-
pletely after treatment, and was removed by wide local exci-
sion (Figure 4). Histological examination ruled out the
presence of cancer and the patient then underwent surgery
to close the colostomy. A year later the patient presented
distant metastases and was subjected to further chemother-
apy. He died one year later.
Case three
A 37-year-old homosexual, HIV positive man was treated
for ten years with antiretroviral therapy. He also hadFigure 3 Endoanal ultrasound (US) showing the tumor invasion
of the anal canal. Endoanal US allowed completion of the staging
and showed the degree of infiltration thus staging the tumor as uT2.
Figure 4 Endoanal ultrasound (US) after treatment. It is evident
a complete regression of the anal tumor.
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ously surgically treated for penile and anal warts. He was ad-
mitted complaining of anal itching and pain, a foul smell
and problems with defecation due to a massive swelling (12
cm × 15 cm) in the perianal region. EUS highlighted that
the lesion also extended into the anal canal (uT1N0). Histo-
logical examination detected the characteristic feature of the
GCA and foci of SCC in the endoanal lesion. PCR
performed on the anal brushing revealed the presence of
HPV-18. A computed tomography confirmed the EUS and
ruled out the presence of pathological lymph nodes and dis-
tant metastasis. The patient underwent chemo-radiotherapy
with the following scheme: 45 Gy (1.8 Gy/fr) to the pelvis
plus a boost with 14.40 Gy (1.8 Gy/fr) to the primary tumor
for a total of 59.4 Gy and mitomycin-C (10 mg/m2) in bolus
on first day plus 5-fluorouracil (750 mg/m2) by continuous
infusion in the first and in the sixth week. He tolerated the
treatment well. The perianal tumor disappeared completely
after treatment, while a small lesion persisted inside the anal
canal was removed by local excision. Histological examin-
ation ruled out the presence of GCA and cancer showing
only fibrous tissue. The patient underwent EUS and HRA
twice a year and computer tomography (CT) scan once a
year. After three years, he is disease free.
Discussion
Giant condyloma acuminatum was first described by
Buschke and Löwenstein as a lesion of the penis in 1925
[7]. Subsequently, it has been observed in the anorectal and
perianal regions [8]. It is a large, exophytic lesion, slow
growing and with a tendency to relapse. A high incidence
of GCA has been reported in the homo and bisexual popu-
lations and recurrent aggressive GCA has been reported in
HIV positive patients [9]. All our cases were homosexual
and HIV positive and treated with antiretroviral drugs. Asregards its etiology, the HPV-6 and HPV-11 are the most
common types identified but HPV-16 and HPV-18 are
also detected especially in cases with foci of SCC [8,10]. In
our patients, we identified HPV-6 in two patients and
HPV-18 in one patient. Especially in HIV patients,
the transformation in SCC should be suspected even in
the presence of a strain not considered carcinogenic. The
histological features are similar to those of condyloma
acuminatum but remarkable thickening of the stratum
corneum, marked papillary proliferation and the tendency
to invade deeply are present [5]. In the past, BLT was not
considered a malignant lesion but a transformation in
squamous cell carcinoma can occur after an average of
five years [3]. Careful histological examination is necessary
to rule out the presence of SCC [5]. In a 2001 systematic
review of the literature, Trombetta et al. found the pres-
ence of neoplastic foci in 23 of 52 patients undergoing
surgery for GCA [11]. GCA differs from SCC in that it
demonstrates an intact basement membrane, infrequent
mitosis, absence of metastases and the tendency to dis-
place deep tissues rather than to infiltrate. When malig-
nant transformation is not detected early, it is no longer
distinguishable from an invasive carcinoma. Topical appli-
cations such as podophyllin and immunotherapy have
been used in the treatment of CGA but without success
[6]. Wide local excision or abdomino-perineal resection
(APR) are considered the treatment of choice of GCA de-
pending on local extension of the lesion and the involve-
ment of the anal canal, but Chu reported a recurrence
rate of 50% after radical surgery alone [3]. In cases of
GCA, an accurate preoperative study is indispensable as
malignant transformation, not always diagnosed before
surgery, was found in a high percentage. In 42 cases of
anorectal GCA reported in the literature, malignant trans-
formation was observed in 52% of the patients [3].
Creasman, in another review, observed malignant trans-
formation in 30% of cases [12]. Thus, we perform EUS
and CT to assess the exact extent of the disease and mul-
tiple biopsies to detect neoplastic transformation. In the
presence of foci of SCC, we believe it advisable to refer pa-
tients to radio-chemotherapy, using the same protocols
adopted in epidermoid cancer of the anus [13-15]. Two
months after the end of treatment, we reevaluate the pa-
tients with endoanal ultrasound, total body CT scan, endos-
copy and HRA. In our patients, the histological examination
performed on a wide local excision has allowed us to ex-
clude the presence of GCA and neoplastic foci which would
indicate a need for APR. Butler et al. reported a case of anal
GCA invading the perineum and pelvis, with foci of SCC
treated by fecal diversion and chemo-radiation. APR was
then performed with no evidence of disease in the resected
specimen [16]. We believe that APR is indicated only in
non-responding patients or in the presence of a large re-
sidual tumor; in all other cases we consider adequate local
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the perianal region and the anal canal, neo-adjuvant radio-
chemotherapy has allowed the preservation of the anal
sphincters and complete cure of the local disease. The pa-
tient who died two years after surgical treatment from dis-
tant metastases had more advanced disease at diagnosis,
with involvement of the inguinal lymph nodes. Despite
this, neo-adjuvant therapy allowed a loco-regional control
of the disease, thus avoiding colostomy. We believe that
the patients treated with this multimodal therapy should
undergo careful clinical and instrumental follow-up to
identify local recurrence in the early stages when it can still
be susceptible to further surgical treatment. Prolonged
follow-up is also indicated because the majority of patients
with GCA are homosexual and HIV positive and, there-
fore, may undergo reinfection with HPV and development
of new cancer of the anus [17].
Conclusion
Neo-adjuvant chemo-radiation therapy with local surgical
excision could be considered an effective therapy in the
treatment of anorectal BLT with SCC transformation to
avoid APR.
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